Franklin Resources’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$88.4M Buy
703,521
+124,092
+21% +$15.6M 0.02% 450
2025
Q1
$64.1M Sell
579,429
-29,506
-5% -$3.26M 0.02% 530
2024
Q4
$83.1M Sell
608,935
-55,401
-8% -$7.56M 0.02% 460
2024
Q3
$77.4M Sell
664,336
-144,114
-18% -$16.8M 0.02% 468
2024
Q2
$111M Buy
808,450
+14,625
+2% +$2.01M 0.03% 387
2024
Q1
$109M Buy
793,825
+21,515
+3% +$2.97M 0.03% 394
2023
Q4
$102M Buy
772,310
+6,124
+0.8% +$807K 0.05% 349
2023
Q3
$86.2M Buy
766,186
+37,936
+5% +$4.27M 0.04% 378
2023
Q2
$68.7M Buy
728,250
+17,806
+3% +$1.68M 0.03% 446
2023
Q1
$71.9M Buy
710,444
+16,672
+2% +$1.69M 0.04% 432
2022
Q4
$82.9M Sell
693,772
-358,463
-34% -$42.8M 0.04% 406
2022
Q3
$112M Sell
1,052,235
-128,820
-11% -$13.7M 0.06% 353
2022
Q2
$115M Buy
1,181,055
+65,313
+6% +$6.37M 0.06% 353
2022
Q1
$105M Buy
1,115,742
+151,921
+16% +$14.2M 0.04% 423
2021
Q4
$82.1M Sell
963,821
-203
-0% -$17.3K 0.03% 508
2021
Q3
$92.5M Buy
964,024
+1,490
+0.2% +$143K 0.03% 488
2021
Q2
$93.7M Buy
962,534
+57,680
+6% +$5.61M 0.04% 482
2021
Q1
$88M Buy
904,854
+9,984
+1% +$971K 0.04% 468
2020
Q4
$85.8M Sell
894,870
-635,290
-42% -$60.9M 0.04% 463
2020
Q3
$147M Buy
1,530,160
+77,878
+5% +$7.49M 0.07% 291
2020
Q2
$189M Sell
1,452,282
-225,399
-13% -$29.4M 0.1% 242
2020
Q1
$145M Sell
1,677,681
-305,818
-15% -$26.5M 0.1% 233
2019
Q4
$213M Buy
1,983,499
+122,980
+7% +$13.2M 0.11% 225
2019
Q3
$168M Buy
1,860,519
+208,688
+13% +$18.8M 0.09% 263
2019
Q2
$139M Sell
1,651,831
-387,307
-19% -$32.7M 0.07% 287
2019
Q1
$180M Buy
2,039,138
+14,200
+0.7% +$1.25M 0.1% 253
2018
Q4
$145M Buy
2,024,938
+184,415
+10% +$13.2M 0.09% 259
2018
Q3
$226M Buy
1,840,523
+15,137
+0.8% +$1.86M 0.11% 218
2018
Q2
$179M Sell
1,825,386
-531,200
-23% -$52.2M 0.09% 243
2018
Q1
$195M Sell
2,356,586
-714,800
-23% -$59.3M 0.1% 226
2017
Q4
$238M Sell
3,071,386
-194,229
-6% -$15.1M 0.11% 209
2017
Q3
$200M Sell
3,265,615
-113,000
-3% -$6.92M 0.1% 230
2017
Q2
$155M Buy
3,378,615
+579,900
+21% +$26.7M 0.08% 262
2017
Q1
$121M Buy
2,798,715
+389,000
+16% +$16.8M 0.06% 316
2016
Q4
$93.3M Buy
2,409,715
+397,429
+20% +$15.4M 0.05% 363
2016
Q3
$102M Buy
2,012,286
+470,840
+31% +$23.8M 0.05% 345
2016
Q2
$70.1M Buy
1,541,446
+380,841
+33% +$17.3M 0.04% 441
2016
Q1
$45.9M Sell
1,160,605
-39,695
-3% -$1.57M 0.02% 554
2015
Q4
$67.9M Sell
1,200,300
-40,400
-3% -$2.29M 0.03% 462
2015
Q3
$49.4M Sell
1,240,700
-113,700
-8% -$4.52M 0.02% 563
2015
Q2
$64.7M Hold
1,354,400
0.03% 520
2015
Q1
$53.8M Sell
1,354,400
-571,600
-30% -$22.7M 0.02% 574
2014
Q4
$43M Buy
1,926,000
+87,600
+5% +$1.96M 0.02% 646
2014
Q3
$28.8M Sell
1,838,400
-365,800
-17% -$5.73M 0.01% 763
2014
Q2
$32.7M Hold
2,204,200
0.01% 735
2014
Q1
$35.5M Buy
2,204,200
+105,600
+5% +$1.7M 0.02% 704
2013
Q4
$19.6M Buy
2,098,600
+495,800
+31% +$4.63M 0.01% 813
2013
Q3
$18.1M Buy
1,602,800
+154,400
+11% +$1.75M 0.01% 825
2013
Q2
$19.4M Buy
+1,448,400
New +$19.4M 0.01% 763